Embryo selection in animal breeding is subjective and labour-intensive, and poor-quality embryo transfers reduce pregnancy rates and waste genetics and recipient animals.
A short microscope video is analysed by machine learning to assess embryo movement, health and viability and return an objective report within seconds.
Solution Effectiveness
The company states that a roughly 30-second video can generate an assessment in seconds. No independent field-wide pregnancy-rate uplift was found in the reviewed public sources.
Investment Funding
Last Funding Stage
Grant
Total Funding Amount
$109K
Last Funding Amount
$4K
Last Funding Date
5/19/2022
Startup Stage
Early Stage
Lead Investors
MedTech Innovator, American Farm Bureau, Femovate, Grow NY, NextCorps Luminate
People
Founders
Cara Wells
Tracy Druce JD
CEO
Cara Wessels Wells
About
Emgenisys is a developer of a proprietary software platform designed to improve animal production and promote sustainability.
Products
Product
EMGenisys embryo-health and viability analysis platform.
Star Product
Embryo viability assessment – the patented core product and clearest commercial differentiator.
Demo Product or Complete Product?
Commercial software/service used by animal-reproduction professionals.
Awards and Recognitions
Certifications
Software supports reproductive decision-making; no regulatory certification requirement or approval was identified on the reviewed pages.
M&A and Collabs
Collab
No second named collaboration was verified.
Something missing or incorrect on this page? Help us enrich this information
